Skip to main content
. 2021 May 28;13(6):1843. doi: 10.3390/nu13061843

Table 3.

Hazard ratios (HRs) and 95% confidence intervals (CIs) for breast cancer (BC) by daily dietary intake of methyl-group donors (MGDs) by levels of alcohol intake in 318,686 women in the EPIC cohort.

Low Alcohol Intake
(<2 Drinks/Week)
(N = 157,363)
Moderate Alcohol Intake
(2–12 Drinks/Week)
(N = 124,578)
High Alcohol Intake
(>12 Drinks/Week)
(N = 36,745)
BC Cases Person Years Multivariable Model a
HR (95% CI)
BC Cases Person Years Multivariable Model a
HR (95% CI)
BC Cases Person Years Multivariable Model a
HR (95% CI)
Pinteraction b, c
MGD score
Continuous (1 unit) 5882 2,241,059 0.99 (0.97–1.01) 5448 1,748,126 1.00 (0.98–1.02) 1990 503,575 1.00 (0.97–1.03) 0.049 b
Q1: ≤ −2.58 1324 504,409 1 (Ref.) 963 307,475 1 (Ref.) 281 73,439 1 (Ref.)
Q2: > −2.58–−1.00 1175 459,463 0.92 (0.85–1.01) 1039 349,334 0.95 (0.86–1.04) 375 89,680 1.12 (0.95–1.32)
Q3: > −1.00–0.39 1154 450,289 0.91 (0.82–1.00) 1134 362,348 1.00 (0.91–1.11) 412 93,145 1.20 (1.01–1.44)
Q4: > 0.39–2.31 1127 433,205 0.90 (0.81–1.01) 1151 369,993 1.00 (0.89–1.12) 390 106,439 1.02 (0.83–1.24)
Q5: > 2.31 1102 393,694 0.90 (0.78–1.04) 1161 358,976 1.02 (0.87–1.19) 532 140,871 1.10 (0.86–1.41) 0.025 c
Ptrend 0.210 0.586 0.867
Dietary folate (µg/day)
Continuous (per 1 SD = 128 µg/day) 5882 2,241,059 0.96 (0.91–1.02) 5448 1,748,126 1.03 (0.97–1.09) 1990 503,575 1.10 (1.00–1.20) 0.063 b
Q1: ≤ 242 1438 533,297 1 (Ref.) 975 298,193 1 (Ref.) 311 71,589 1 (Ref.)
Q2: > 242–298 1211 458,111 0.93 (0.86–1.02) 1076 350,013 0.98 (0.89–1.08) 397 93,099 1.02 (0.87–1.19)
Q3: > 298–357 1067 431,110 0.85 (0.77–0.94) 1113 366,994 1.02 (0.92–1.13) 389 101,785 0.95 (0.80–1.13)
Q4: > 357–440 1101 417,655 0.89 (0.79–0.99) 1152 368,818 1.09 (0.97–1.23) 430 109,863 1.00 (0.82–1.22)
Q5: > 440 1065 400,886 0.85 (0.74–0.98) 1132 364,109 1.12 (0.96–1.31) 463 127,239 1.00 (0.78–1.29) 0.231 c
Ptrend 0.052 0.059 0.998
Dietary choline (mg/day)
Continuous (per 1 SD = 90 mg/day) 5882 2,241,059 0.99 (0.95–1.02) 5448 174,8126 1.01 (0.97–1.05) 1990 503,575 1.01 (0.95–1.07) 0.064 b
Q1: ≤ 202 1365 535,685 1 (Ref.) 858 284,036 1 (Ref.) 225 61,666 1 (Ref.)
Q2: < 202–244 1226 471,093 0.97 (0.90–1.06) 1055 337,077 1.03 (0.94–1.13) 345 85,676 1.12 (0.94–1.33)
Q3: < 244–285 1136 444,750 0.94 (0.86–1.03) 1038 359,764 0.94 (0.85–1.03) 380 99,898 1.06 (0.89–1.27)
Q4: < 285–339 1106 418,570 0.94 (0.85–1.04) 1171 378,671 0.98 (0.88–1.09) 439 112,623 1.09 (0.91–1.31)
Q5: > 339 1049 370,961 0.92 (0.82–1.04) 1326 388,578 1.04 (0.92–1.17) 601 143,712 1.13 (0.93–1.38) 0.292 c
Ptrend 0.177 0.577 0.344
Dietary betaine (mg/day)
Continuous (per 1 SD = 88 mg /day) 5882 2,241,059 1.01 (0.97–1.04) 5448 1,748,126 0.96 (0.92–1.00) 1990 503,575 1.02 (0.95–1.08) 0.037 b
Q1: ≤ 39 1089 378,757 1 (Ref.) 1254 359,896 1 (Ref.) 440 102,142 1 (Ref.)
Q2: < 39–88 1160 464,885 0.93 (0.85–1.03) 1240 373,502 0.96 (0.87–1.05) 416 98,141 1.06 (0.91–1.24)
Q3: < 88–132 1264 474,910 1.01 (0.91–1.13) 1031 342,637 0.92 (0.83–1.03) 364 88,983 1.19 (0.99–1.44)
Q4: < 132–193 1194 447,685 1.03 (0.92–1.15) 1040 353,835 0.94 (0.83–1.05) 408 107,715 1.13 (0.93–1.38)
Q5: > 193 1175 474,821 0.98 (0.87–1.10) 883 318,255 0.89 (0.79–1.02) 362 106,593 1.12 (0.90–1.39) 0.221 c
Ptrend 0.741 0.126 0.497
Dietary methionine (g/day)
Continuous (per 1 g/day) 5882 2,241,059 0.95 (0.88–1.02) 5448 1,748,126 1.02 (0.94–1.10) 1990 503,575 0.88 (0.77–1.00) 0.018 b
Q1: ≤ 1.06 1175 510,519 1 (Ref.) 826 321,954 1 (Ref.) 281 78,502 1 (Ref.)
Q2: < 1.06–1.30 1230 469,493 1.05 (0.96–1.14) 1033 339,137 1.01 (0.92–1.11) 328 87,739 0.94 (0.80–1.11)
Q3: < 1.30–1.54 1220 451,112 1.03 (0.95–1.13) 1093 353,461 0.99 (0.89–1.09) 418 94,445 1.09 (0.92–1.28)
Q4: < 1.54–1.85 1140 423,892 0.99 (0.90–1.09) 1226 367,949 1.02 (0.9–1.14) 449 106,363 1.02 (0.86–1.22)
Q5: > 1.85 1117 386,043 0.98 (0.87–1.10) 1270 365,624 1.03 (0.91–1.16) 514 136,526 0.87 (0.71–1.07) 0.023 c
Ptrend 0.460 0.581 0.200

a Multivariable model: Cox regression model stratified by study center and by one year categories of age at recruitment and adjusted for total energy intake (kcal/day), dietary fiber intake (g/day), height (cm), BMI (kg/m2), highest level of education (primary/no schooling, technical/professional/secondary, longer education, unknown), physical activity (inactive, moderately inactive, moderately active, active, unknown), smoking status (never, former, current smoker, unknown), ever use of vitamin/mineral supplements (yes, no, unknown), menopausal status at recruitment (premenopausal, postmenopausal (including surgical postmenopausal), perimenopausal), age at menarche (≤12, 13, 14, ≥15), ever use of hormones for menopause (no, yes, unknown), ever use of contraceptive pill (no, yes, unknown), and age at first full term pregnancy (nulliparous, ≤21 year, 22–29 year, ≥30 year). b Pinteraction between MGDs and alcohol intake when considering the MGDs as continuous variables and alcohol intake as a categorical variable (low, moderate and high alcohol consumers). c Pinteraction between MGDs and alcohol intake when considering the MGDs as categorical variables (quintiles) and alcohol intake as a categorical variable (low, moderate and high alcohol consumers). Abbreviations: HR: hazard ratio; CI: confidence interval; BC: breast cancer; Q: quintile; MGD: methyl-group donor; Ref: reference; N: number of participants; SD: standard deviation.